Logo
T

Telesis Bio

118 employees

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cancer research
T-cell therapy
Gene synthesis
Gibson Assembly HiFi kit
Archetype software
Health Care
Protein engineering
Error-free clones
Precision medicine
Custom cloning
Bioinformatics
DNA libraries
Bioinformatic services
Enzyme engineering
mRNA
Reagents
CAR-T
Antibody engineering
Next-generation sequencing
Plasmid preparation

Date founded

2013

Funding rounds raised

Total raised

$74M

from 3 investors over 3 rounds

T

Telesis Bio raised $74M on May 31, 2023

Investors: Novalis LifeSciences LLC, BroadOak Capital Partners and Northpond Ventures

FAQ